Kiniksa Pharmaceuticals Ownership 2024 | Who Owns Kiniksa Pharmaceuticals Now?
Institutional Ownership
55.34%
Insider Ownership
4.28%
Retail Ownership
40.38%
Institutional Holders
160.00
Kiniksa Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.96% | 0.00% | 4,193,907 | 1,013,319 | 31.86% | 82,745,786 | Mar 31, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 4.55% | 6.89% | 3,204,841 | 321,620 | 11.15% | 63,231,513 | Mar 31, 2024 |
| HHLR ADVISORS, LTD. | 4.46% | 1.34% | 3,135,735 | 3,135,735 | 100.00% | 61,868,052 | Mar 31, 2024 |
| VANGUARD GROUP INC | 4.24% | 0.00% | 2,981,894 | 16,595 | 0.56% | 58,832,768 | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | 3.99% | 0.70% | 2,809,577 | - | - | 55,432,954 | Mar 31, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.12% | 1.28% | 2,196,009 | -711,492 | -24.47% | 43,327,258 | Mar 31, 2024 |
| STATE STREET CORP | 2.68% | 0.00% | 1,888,544 | 342,448 | 22.15% | 37,260,973 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.08% | 0.03% | 1,460,633 | -110,183 | -7.01% | 28,818,289 | Mar 31, 2024 |
| BRAIDWELL LP | 1.98% | 0.89% | 1,392,716 | 1,392,716 | 100.00% | 27,478,287 | Mar 31, 2024 |
| MORGAN STANLEY | 1.81% | 0.00% | 1,270,613 | -324,866 | -20.36% | 25,069,195 | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.18% | 0.00% | 831,099 | 420,075 | 102.20% | 16,397,584 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 1.08% | 0.00% | 760,107 | -149,105 | -16.40% | 14,996,911 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.03% | 0.00% | 725,511 | 25,898 | 3.70% | 14,316,283 | Mar 31, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 0.95% | 0.15% | 666,976 | -47,903 | -6.70% | 13,159,436 | Mar 31, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.92% | 0.45% | 648,087 | -74,301 | -10.29% | 12,786,757 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.92% | 1.56% | 646,163 | 30,470 | 4.95% | 12,748,796 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.88% | 0.12% | 622,540 | -39,175 | -5.92% | 12,282,714 | Mar 31, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.88% | 0.70% | 618,798 | -17,231 | -2.71% | 12,208,885 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.72% | 0.00% | 506,299 | 156,546 | 44.76% | 9,989,280 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.71% | 1.03% | 500,000 | -100,000 | -16.67% | 9,865,000 | Mar 31, 2024 |
Kiniksa Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 5.96% of the company's total share outstanding, currently valued at $82.75M. The top 10 institutional shareholders own together 34.86% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FAIRMOUNT FUNDS MANAGEMENT LLC | 4.55% | 6.89% | 3,204,841 | 321,620 | 11.15% | 63,231,513 | Mar 31, 2024 |
| ALTITUDE CREST PARTNERS INC. | 0.57% | 3.38% | 400,441 | -55,600 | -12.19% | 7,900,701 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.92% | 1.56% | 646,163 | 30,470 | 4.95% | 12,748,796 | Mar 31, 2024 |
| LION POINT CAPITAL, LP | 0.19% | 1.44% | 130,691 | - | - | 2,578,533 | Mar 31, 2024 |
| HHLR ADVISORS, LTD. | 4.46% | 1.34% | 3,135,735 | 3,135,735 | 100.00% | 61,868,052 | Mar 31, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 3.12% | 1.28% | 2,196,009 | -711,492 | -24.47% | 43,327,258 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.71% | 1.03% | 500,000 | -100,000 | -16.67% | 9,865,000 | Mar 31, 2024 |
| BRAIDWELL LP | 1.98% | 0.89% | 1,392,716 | 1,392,716 | 100.00% | 27,478,287 | Mar 31, 2024 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 0.22% | 0.72% | 157,500 | 157,500 | 100.00% | 3,107,475 | Mar 31, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.88% | 0.70% | 618,798 | -17,231 | -2.71% | 12,208,885 | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | 3.99% | 0.70% | 2,809,577 | - | - | 55,432,954 | Mar 31, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.25% | 0.67% | 172,740 | 850 | 0.49% | 3,408,160 | Mar 31, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.13% | 0.62% | 88,688 | - | - | 1,749,814 | Mar 31, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.04% | 0.48% | 30,000 | - | - | 591,900 | Mar 31, 2024 |
| OPTIONS SOLUTIONS, LLC | 0.06% | 0.45% | 40,205 | 40,205 | 100.00% | 793,245 | Mar 31, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.92% | 0.45% | 648,087 | -74,301 | -10.29% | 12,786,757 | Mar 31, 2024 |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 0.08% | 0.38% | 54,384 | 54,384 | 100.00% | 1,073,000 | Mar 31, 2024 |
| LINDEN THOMAS ADVISORY SERVICES, LLC | 0.17% | 0.37% | 116,381 | 1,831 | 1.60% | 2,296,197 | Mar 31, 2024 |
| TEJARA CAPITAL LTD | 0.06% | 0.31% | 42,649 | -52,500 | -55.18% | 841,465 | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.08% | 0.27% | 59,700 | -45,300 | -43.14% | 1,177,881 | Mar 31, 2024 |
The largest Kiniksa Pharmaceuticals shareholder by % of total assets is FAIRMOUNT FUNDS MANAGEMENT LLC. The company owns 3.20M shares of Kiniksa Pharmaceuticals (KNSA), representing 6.89% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. | 4.46% | 1.34% | 3,135,735 | 3,135,735 | 100.00% | 61,868,052 | Mar 31, 2024 |
| BRAIDWELL LP | 1.98% | 0.89% | 1,392,716 | 1,392,716 | 100.00% | 27,478,287 | Mar 31, 2024 |
| BLACKROCK INC. | 5.96% | 0.00% | 4,193,907 | 1,013,319 | 31.86% | 82,745,786 | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.18% | 0.00% | 831,099 | 420,075 | 102.20% | 16,397,584 | Mar 31, 2024 |
| STATE STREET CORP | 2.68% | 0.00% | 1,888,544 | 342,448 | 22.15% | 37,260,973 | Mar 31, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 4.55% | 6.89% | 3,204,841 | 321,620 | 11.15% | 63,231,513 | Mar 31, 2024 |
| PEREGRINE CAPITAL MANAGEMENT LLC | 0.34% | 0.13% | 236,045 | 236,045 | 100.00% | 4,657,168 | Mar 31, 2024 |
| KNIGHTS OF COLUMBUS ASSET ADVISORS LLC | 0.23% | 0.23% | 162,283 | 162,283 | 100.00% | 3,201,844 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.30% | 0.00% | 212,505 | 161,962 | 320.44% | 4,192,724,000 | Mar 31, 2024 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 0.22% | 0.72% | 157,500 | 157,500 | 100.00% | 3,107,475 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.72% | 0.00% | 506,299 | 156,546 | 44.76% | 9,989,280 | Mar 31, 2024 |
| CITIGROUP INC | 0.27% | 0.00% | 191,020 | 144,662 | 312.05% | 3,768,825 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.19% | 0.00% | 131,800 | 131,800 | 100.00% | 2,600,414 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.19% | 0.00% | 131,223 | 131,223 | 100.00% | 2,589,030 | Mar 31, 2024 |
| NORDEA INVESTMENT MANAGEMENT AB | 0.18% | 0.00% | 126,742 | 126,742 | 100.00% | 2,486,678 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.17% | 0.00% | 122,100 | 122,100 | 100.00% | 2,409,033 | Mar 31, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.26% | 0.00% | 185,813 | 109,061 | 142.10% | 3,666,000 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.23% | 0.01% | 164,568 | 103,120 | 167.82% | 3,240,000 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.12% | 0.00% | 84,493 | 84,493 | 100.00% | 1,667,047 | Mar 31, 2024 |
| SEI INVESTMENTS CO | 0.10% | 0.00% | 73,481 | 73,481 | 100.00% | 1,449,790 | Mar 31, 2024 |
As of Mar 31 2024, Kiniksa Pharmaceuticals's largest institutional buyer is HHLR ADVISORS, LTD.. The company purchased 3.14M stocks of KNSA, valued at $61.87M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 3.12% | 1.28% | 2,196,009 | -711,492 | -24.47% | 43,327,258 | Mar 31, 2024 |
| GMT CAPITAL CORP | - | - | - | -341,553 | -100.00% | - | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -327,332 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | 1.81% | 0.00% | 1,270,613 | -324,866 | -20.36% | 25,069,195 | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -296,200 | -100.00% | - | Mar 31, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -227,500 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.34% | 0.00% | 239,409 | -188,926 | -44.11% | 4,723,540 | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -183,102 | -100.00% | - | Mar 31, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -150,000 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 1.08% | 0.00% | 760,107 | -149,105 | -16.40% | 14,996,911 | Mar 31, 2024 |
| BARCLAYS PLC | 0.06% | 0.00% | 42,147 | -143,609 | -77.31% | 831,000 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.08% | 0.03% | 1,460,633 | -110,183 | -7.01% | 28,818,289 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.15% | 0.00% | 105,290 | -109,406 | -50.96% | 2,077,372 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.71% | 1.03% | 500,000 | -100,000 | -16.67% | 9,865,000 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -83,572 | -100.00% | - | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | 0.32% | 0.00% | 221,853 | -82,752 | -27.17% | 4,377,160 | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -74,866 | -100.00% | - | Mar 31, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.92% | 0.45% | 648,087 | -74,301 | -10.29% | 12,786,757 | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.12% | 0.00% | 84,155 | -72,586 | -46.31% | 1,660,378 | Mar 31, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.23% | 0.01% | 159,323 | -68,722 | -30.14% | 3,143,442 | Mar 31, 2024 |
As of Mar 31 2024, Kiniksa Pharmaceuticals's biggest institutional seller is RUBRIC CAPITAL MANAGEMENT LP. The company sold -0.71M shares of KNSA, valued at $43.33M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRAIDWELL LP | 1.98% | 0.89% | 1,392,716 | 1,392,716 | 100.00% | 27,478,287 | Mar 31, 2024 |
| PEREGRINE CAPITAL MANAGEMENT LLC | 0.34% | 0.13% | 236,045 | 236,045 | 100.00% | 4,657,168 | Mar 31, 2024 |
| KNIGHTS OF COLUMBUS ASSET ADVISORS LLC | 0.23% | 0.23% | 162,283 | 162,283 | 100.00% | 3,201,844 | Mar 31, 2024 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 0.22% | 0.72% | 157,500 | 157,500 | 100.00% | 3,107,475 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.19% | 0.00% | 131,800 | 131,800 | 100.00% | 2,600,414 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.19% | 0.00% | 131,223 | 131,223 | 100.00% | 2,589,030 | Mar 31, 2024 |
| NORDEA INVESTMENT MANAGEMENT AB | 0.18% | 0.00% | 126,742 | 126,742 | 100.00% | 2,486,678 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.17% | 0.00% | 122,100 | 122,100 | 100.00% | 2,409,033 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.12% | 0.00% | 84,493 | 84,493 | 100.00% | 1,667,047 | Mar 31, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.09% | 0.01% | 59,954 | 59,954 | 100.00% | 1,182,892 | Mar 31, 2024 |
| OPTIONS SOLUTIONS, LLC | 0.06% | 0.45% | 40,205 | 40,205 | 100.00% | 793,245 | Mar 31, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.05% | 0.00% | 34,062 | 34,062 | 100.00% | 672,043 | Mar 31, 2024 |
| CERITY PARTNERS LLC | 0.04% | 0.00% | 29,683 | 29,683 | 100.00% | 585,645 | Mar 31, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 17,856 | 17,856 | 100.00% | 352,299 | Mar 31, 2024 |
| HSBC HOLDINGS PLC | 0.02% | 0.00% | 16,356 | 16,356 | 100.00% | 322,704 | Mar 31, 2024 |
| PEAK6 INVESTMENTS LLC | 0.02% | 0.00% | 15,000 | 15,000 | 100.00% | 295,950 | Mar 31, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.02% | 0.00% | 13,467 | 13,467 | 100.00% | 144,905 | Mar 31, 2024 |
| MARINER, LLC | 0.02% | 0.00% | 13,427 | 13,427 | 100.00% | 264,915,000 | Mar 31, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | 0.02% | 0.03% | 13,142 | 13,142 | 100.00% | 259,000 | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.02% | 0.02% | 11,245 | 11,245 | 100.00% | 221,864 | Mar 31, 2024 |
| ALGERT GLOBAL LLC | 0.01% | 0.01% | 10,447 | 10,447 | 100.00% | 206,000 | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | 0.01% | 0.00% | 6,000 | 6,000 | 100.00% | 118,380 | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | 0.00% | 5,049 | 5,049 | 100.00% | 99,000 | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | 0.00% | 2,175 | 2,175 | 100.00% | 42,913 | Mar 31, 2024 |
| VIRTUS FUND ADVISERS, LLC | 0.00% | 0.09% | 1,236 | 1,236 | 100.00% | 24,386 | Mar 31, 2024 |
| PACER ADVISORS, INC. | 0.00% | - | 660 | 660 | 100.00% | 13,022 | Mar 31, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.00% | - | 500 | 500 | 100.00% | 9,761 | Mar 31, 2024 |
| US BANCORP \DE\ | 0.00% | - | 116 | 116 | 100.00% | 2,289 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 34 | 34 | 100.00% | 670 | Mar 31, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | 0.00% | 30 | 30 | 100.00% | 592 | Mar 31, 2024 |
Kiniksa Pharmaceuticals's largest new institutional shareholder by number of shares is BRAIDWELL LP, purchased 1.39M shares, valued at $27.48M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GMT CAPITAL CORP | - | - | - | -341,553 | -100.00% | - | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -327,332 | -100.00% | - | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -296,200 | -100.00% | - | Mar 31, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -227,500 | -100.00% | - | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -183,102 | -100.00% | - | Mar 31, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -150,000 | -100.00% | - | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -83,572 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -74,866 | -100.00% | - | Mar 31, 2024 |
| ENSIGN PEAK ADVISORS, INC | - | - | - | -66,443 | -100.00% | - | Mar 31, 2024 |
| ADVISORY RESEARCH INC | - | - | - | -65,450 | -100.00% | - | Mar 31, 2024 |
| OPALEYE MANAGEMENT INC. | - | - | - | -37,500 | -100.00% | - | Mar 31, 2024 |
| WALLEYE TRADING LLC | - | - | - | -21,424 | -100.00% | - | Mar 31, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | - | - | - | -14,509 | -100.00% | - | Mar 31, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | - | - | - | -12,546 | -100.00% | - | Mar 31, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -12,180 | -100.00% | - | Mar 31, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -12,160 | -100.00% | - | Mar 31, 2024 |
| STATE OF WYOMING | - | - | - | -2,342 | -100.00% | - | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -1,743 | -100.00% | - | Mar 31, 2024 |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | - | - | - | -300 | -100.00% | - | Mar 31, 2024 |
| PLANNED SOLUTIONS, INC. | - | - | - | -200 | -100.00% | - | Mar 31, 2024 |
| COVESTOR LTD | - | - | - | -53 | -100.00% | - | Mar 31, 2024 |
Kiniksa Pharmaceuticals's largest sold out institutional shareholder by shares sold is GMT CAPITAL CORP, sold -0.34M shares, valued at -, as of undefined.
Kiniksa Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| WANGER ADVISORS TRUST | 0.43% | 272,453 | - | - | Dec 31, 2023 |
| COLUMBIA ACORN TRUST | 0.32% | 1,098,682 | - | - | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 21,265 | - | - | Dec 31, 2023 |
| FORUM FUNDS II | 0.01% | 13,176 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.01% | 248 | - | - | Dec 31, 2023 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 80,011 | 21,682 | 37.17% | Dec 29, 2023 |
| VANGUARD INDEX FUNDS | 0.01% | 3,086,260 | 490,110 | 18.88% | Dec 31, 2023 |
| CLEARWATER INVESTMENT TRUST | 0.01% | 47,116 | - | - | Dec 29, 2023 |
| ALPS ETF Trust | 0.00% | 43,040 | -25,965 | -37.63% | Feb 29, 2024 |
| JAMES ADVANTAGE FUNDS | 0.00% | 6,909 | - | - | Dec 31, 2023 |
| Destra Investment Trust | 0.00% | 5,116 | -2,023 | -28.34% | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 706 | - | - | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.00% | 36,699 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 7,893 | -138 | -1.72% | Dec 31, 2023 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 186,740 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 14,683 | - | - | Jan 31, 2024 |
| TIMOTHY PLAN | 0.00% | 6,920 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 43,640 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 10,646 | 5,009 | 88.86% | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 22,257 | - | - | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 17,844 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 19,941 | - | - | Dec 31, 2023 |
| Brinker Capital Destinations Trust | 0.00% | 40,976 | -16,853 | -29.14% | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 92,039 | -17,202 | -15.75% | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 27,696 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 96,431 | 2,106 | 2.23% | Feb 29, 2024 |
| Trust for Advised Portfolios | 0.00% | 5,797 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 110,913 | 81,213 | 273.44% | Jan 31, 2024 |
| GPS Funds I | 0.00% | 978 | - | - | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 21,729 | 2,213 | 11.34% | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 41,731 | 30,954 | 287.22% | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 801 | - | - | Dec 31, 2023 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 375 | -18,666 | -98.03% | Feb 29, 2024 |
| Meeder Funds | 0.00% | 496 | - | - | Mar 31, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 6,122 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 137,400 | 13,950 | 11.30% | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 21,700 | 9,353 | 75.75% | Feb 29, 2024 |
| Victory Portfolios II | 0.00% | 3,036 | -3,391 | -52.76% | Dec 31, 2023 |
| RBB FUND, INC. | 0.00% | 4,885 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 141,651 | -90,335 | -38.94% | Dec 31, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 3,029 | - | - | Feb 29, 2024 |
| Pacer Funds Trust | 0.00% | 1,637 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 30,323 | -569 | -1.84% | Dec 29, 2023 |
| MUTUAL FUND SERIES TRUST | 0.00% | 110,000 | - | - | Dec 31, 2023 |
| THRIVENT SERIES FUND INC | 0.00% | 3,209 | - | - | Dec 29, 2023 |
| PGIM ETF TRUST | 0.00% | 1,914 | - | - | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 5,691 | - | - | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 442 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,073 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 11,321 | -153,480 | -93.13% | Dec 31, 2023 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 514 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 102 | 18 | 21.43% | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 126,554 | 42,359 | 50.31% | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 12,369 | -432 | -3.37% | Dec 31, 2023 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 27,381 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 943 | 330 | 53.83% | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,269 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 13,485 | 898 | 7.13% | Dec 31, 2023 |
| John Hancock Funds II | 0.00% | 3,468 | - | - | Feb 29, 2024 |
Kiniksa Pharmaceuticals's largest mutual fund holder by % of total assets is "WANGER ADVISORS TRUST", owning 272.45K shares, compromising 0.43% of its total assets.
Kiniksa Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 160 | 8.84% |
| 31 Dec, 23 | 147 | 3.52% |
| 30 Sep, 23 | 142 | 6.77% |
| 30 Jun, 23 | 133 | -3.62% |
| 31 Mar, 23 | 138 | 3.76% |
| 31 Dec, 22 | 133 | 17.70% |
| 30 Sep, 22 | 113 | 18.95% |
| 30 Jun, 22 | 95 | -5.94% |
| 31 Mar, 22 | 101 | -5.61% |
| 31 Dec, 21 | 107 | 0.94% |
| 30 Sep, 21 | 106 | -6.19% |
| 30 Jun, 21 | 113 | -1.74% |
| 31 Mar, 21 | 115 | 1.77% |
| 31 Dec, 20 | 113 | 4.63% |
| 30 Sep, 20 | 108 | 13.68% |
| 30 Jun, 20 | 95 | 25.00% |
| 31 Mar, 20 | 76 | 24.59% |
| 31 Dec, 19 | 61 | 15.09% |
| 30 Sep, 19 | 53 | -13.11% |
| 30 Jun, 19 | 61 | 8.93% |
| 31 Mar, 19 | 56 | 7.69% |
| 31 Dec, 18 | 52 | -3.70% |
| 30 Sep, 18 | 54 | 31.71% |
| 30 Jun, 18 | 41 | - |
As of 31 Mar 24, 160 institutions are holding Kiniksa Pharmaceuticals's shares, representing an increase of 8.84% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 38,944,112 | 13.89% |
| 31 Dec, 23 | 34,195,892 | -1.41% |
| 30 Sep, 23 | 34,684,416 | 9.13% |
| 30 Jun, 23 | 31,782,499 | 0.21% |
| 31 Mar, 23 | 31,715,927 | 4.86% |
| 31 Dec, 22 | 30,244,934 | 1.09% |
| 30 Sep, 22 | 29,920,261 | -0.02% |
| 30 Jun, 22 | 29,927,684 | -2.67% |
| 31 Mar, 22 | 30,749,717 | 4.89% |
| 31 Dec, 21 | 29,316,417 | 1.04% |
| 30 Sep, 21 | 29,014,135 | 0.83% |
| 30 Jun, 21 | 28,774,053 | -0.74% |
| 31 Mar, 21 | 28,987,548 | -2.59% |
| 31 Dec, 20 | 29,759,775 | 3.78% |
| 30 Sep, 20 | 28,676,863 | 35.67% |
| 30 Jun, 20 | 21,136,794 | 19.49% |
| 31 Mar, 20 | 17,688,966 | 17.04% |
| 31 Dec, 19 | 15,113,844 | -2.72% |
| 30 Sep, 19 | 15,536,525 | -6.27% |
| 30 Jun, 19 | 16,575,983 | 1.56% |
| 31 Mar, 19 | 16,320,893 | 18.97% |
| 31 Dec, 18 | 13,718,366 | -4.87% |
| 30 Sep, 18 | 14,420,957 | -16.46% |
| 30 Jun, 18 | 17,262,299 | - |
Kiniksa Pharmaceuticals (KNSA) has 38.94M shares outstanding as of 31 Mar 24, up 13.89% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 55.34% | 2.33% |
| 31 Dec, 23 | 48.72% | 1.98% |
| 30 Sep, 23 | 49.61% | 2.39% |
| 30 Jun, 23 | 45.57% | 2.20% |
| 31 Mar, 23 | 45.47% | 2.41% |
| 31 Dec, 22 | 43.45% | 2.34% |
| 30 Sep, 22 | 43.08% | 2.31% |
| 30 Jun, 22 | 43.19% | 2.18% |
| 31 Mar, 22 | 44.48% | 2.43% |
| 31 Dec, 21 | 42.75% | 2.39% |
| 30 Sep, 21 | 42.26% | 2.39% |
| 30 Jun, 21 | 42.07% | 2.33% |
| 31 Mar, 21 | 42.46% | 2.22% |
| 31 Dec, 20 | 43.72% | 2.31% |
| 30 Sep, 20 | 43.48% | 3.26% |
| 30 Jun, 20 | 36.50% | 3.57% |
| 31 Mar, 20 | 31.97% | 4.09% |
| 31 Dec, 19 | 27.96% | 3.48% |
| 30 Sep, 19 | 28.34% | 3.06% |
| 30 Jun, 19 | 30.43% | 3.06% |
| 31 Mar, 19 | 31.53% | 3.93% |
| 31 Dec, 18 | 28.31% | 3.20% |
| 30 Sep, 18 | 29.76% | 0.43% |
| 30 Jun, 18 | 83.04% | - |
As of 31 Mar 24, Kiniksa Pharmaceuticals is held by 55.34% institutional shareholders, representing a 2.33% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 85 | 25.00% |
| 31 Dec, 23 | 68 | - |
| 30 Sep, 23 | 68 | - |
| 30 Jun, 23 | 68 | -12.82% |
| 31 Mar, 23 | 78 | 8.33% |
| 31 Dec, 22 | 72 | 20.00% |
| 30 Sep, 22 | 60 | 39.53% |
| 30 Jun, 22 | 43 | -10.42% |
| 31 Mar, 22 | 48 | -22.58% |
| 31 Dec, 21 | 62 | 10.71% |
| 30 Sep, 21 | 56 | 7.69% |
| 30 Jun, 21 | 52 | 4.00% |
| 31 Mar, 21 | 50 | -19.35% |
| 31 Dec, 20 | 62 | -17.33% |
| 30 Sep, 20 | 75 | 4.17% |
| 30 Jun, 20 | 72 | 63.64% |
| 31 Mar, 20 | 44 | 7.32% |
| 31 Dec, 19 | 41 | 51.85% |
| 30 Sep, 19 | 27 | -30.77% |
| 30 Jun, 19 | 39 | -2.50% |
| 31 Mar, 19 | 40 | 60.00% |
| 31 Dec, 18 | 25 | -32.43% |
| 30 Sep, 18 | 37 | -9.76% |
| 30 Jun, 18 | 41 | - |
85 institutional shareholders have increased their position in KNSA stock as of 31 Mar 24 compared to 68 in the previous quarter (a 25.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 48 | -14.29% |
| 31 Dec, 23 | 56 | 24.44% |
| 30 Sep, 23 | 45 | 7.14% |
| 30 Jun, 23 | 42 | 23.53% |
| 31 Mar, 23 | 34 | -2.86% |
| 31 Dec, 22 | 35 | 20.69% |
| 30 Sep, 22 | 29 | 11.54% |
| 30 Jun, 22 | 26 | -10.34% |
| 31 Mar, 22 | 29 | 11.54% |
| 31 Dec, 21 | 26 | - |
| 30 Sep, 21 | 26 | -16.13% |
| 30 Jun, 21 | 31 | -20.51% |
| 31 Mar, 21 | 39 | 44.44% |
| 31 Dec, 20 | 27 | 68.75% |
| 30 Sep, 20 | 16 | 14.29% |
| 30 Jun, 20 | 14 | -41.67% |
| 31 Mar, 20 | 24 | 100.00% |
| 31 Dec, 19 | 12 | -20.00% |
| 30 Sep, 19 | 15 | 15.38% |
| 30 Jun, 19 | 13 | 160.00% |
| 31 Mar, 19 | 5 | -66.67% |
| 31 Dec, 18 | 15 | 50.00% |
| 30 Sep, 18 | 10 | - |
| 30 Jun, 18 | - | - |
48 institutional shareholders have reduced their position in KNSA stock as of 31 Mar 24 compared to 56 in the previous quarter (a -14.29% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 160 | 8.84% | 38,944,112 | 13.89% | 55.34% | 2.33% | 85 | 25.00% | 48 | -14.29% |
| 31 Dec, 23 | 147 | 3.52% | 34,195,892 | -1.41% | 48.72% | 1.98% | 68 | - | 56 | 24.44% |
| 30 Sep, 23 | 142 | 6.77% | 34,684,416 | 9.13% | 49.61% | 2.39% | 68 | - | 45 | 7.14% |
| 30 Jun, 23 | 133 | -3.62% | 31,782,499 | 0.21% | 45.57% | 2.20% | 68 | -12.82% | 42 | 23.53% |
| 31 Mar, 23 | 138 | 3.76% | 31,715,927 | 4.86% | 45.47% | 2.41% | 78 | 8.33% | 34 | -2.86% |
| 31 Dec, 22 | 133 | 17.70% | 30,244,934 | 1.09% | 43.45% | 2.34% | 72 | 20.00% | 35 | 20.69% |
| 30 Sep, 22 | 113 | 18.95% | 29,920,261 | -0.02% | 43.08% | 2.31% | 60 | 39.53% | 29 | 11.54% |
| 30 Jun, 22 | 95 | -5.94% | 29,927,684 | -2.67% | 43.19% | 2.18% | 43 | -10.42% | 26 | -10.34% |
| 31 Mar, 22 | 101 | -5.61% | 30,749,717 | 4.89% | 44.48% | 2.43% | 48 | -22.58% | 29 | 11.54% |
| 31 Dec, 21 | 107 | 0.94% | 29,316,417 | 1.04% | 42.75% | 2.39% | 62 | 10.71% | 26 | - |
| 30 Sep, 21 | 106 | -6.19% | 29,014,135 | 0.83% | 42.26% | 2.39% | 56 | 7.69% | 26 | -16.13% |
| 30 Jun, 21 | 113 | -1.74% | 28,774,053 | -0.74% | 42.07% | 2.33% | 52 | 4.00% | 31 | -20.51% |
| 31 Mar, 21 | 115 | 1.77% | 28,987,548 | -2.59% | 42.46% | 2.22% | 50 | -19.35% | 39 | 44.44% |
| 31 Dec, 20 | 113 | 4.63% | 29,759,775 | 3.78% | 43.72% | 2.31% | 62 | -17.33% | 27 | 68.75% |
| 30 Sep, 20 | 108 | 13.68% | 28,676,863 | 35.67% | 43.48% | 3.26% | 75 | 4.17% | 16 | 14.29% |
| 30 Jun, 20 | 95 | 25.00% | 21,136,794 | 19.49% | 36.50% | 3.57% | 72 | 63.64% | 14 | -41.67% |
| 31 Mar, 20 | 76 | 24.59% | 17,688,966 | 17.04% | 31.97% | 4.09% | 44 | 7.32% | 24 | 100.00% |
| 31 Dec, 19 | 61 | 15.09% | 15,113,844 | -2.72% | 27.96% | 3.48% | 41 | 51.85% | 12 | -20.00% |
| 30 Sep, 19 | 53 | -13.11% | 15,536,525 | -6.27% | 28.34% | 3.06% | 27 | -30.77% | 15 | 15.38% |
| 30 Jun, 19 | 61 | 8.93% | 16,575,983 | 1.56% | 30.43% | 3.06% | 39 | -2.50% | 13 | 160.00% |
| 31 Mar, 19 | 56 | 7.69% | 16,320,893 | 18.97% | 31.53% | 3.93% | 40 | 60.00% | 5 | -66.67% |
| 31 Dec, 18 | 52 | -3.70% | 13,718,366 | -4.87% | 28.31% | 3.20% | 25 | -32.43% | 15 | 50.00% |
| 30 Sep, 18 | 54 | 31.71% | 14,420,957 | -16.46% | 29.76% | 0.43% | 37 | -9.76% | 10 | - |
| 30 Jun, 18 | 41 | - | 17,262,299 | - | 83.04% | - | 41 | - | - | - |
Kiniksa Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Kiniksa Pharmaceuticals's stock was made by Levy Richard S on May 07 2024, selling 747 shares at - per share (valued at -).
Kiniksa Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 29 | 24 | 120.83% |
| Q1 2024 | 9 | 19 | 47.37% |
| Q4 2023 | 5 | 10 | 50.00% |
| Q3 2023 | 28 | 30 | 93.33% |
| Q2 2023 | 47 | 13 | 361.54% |
| Q1 2023 | 14 | 24 | 58.33% |
| Q4 2022 | 3 | 6 | 50.00% |
| Q3 2022 | 14 | 12 | 116.67% |
| Q2 2022 | 25 | 2 | 1250.00% |
| Q1 2022 | 12 | 23 | 52.17% |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 17 | - | - |
| Q2 2021 | 9 | 24 | 37.50% |
| Q1 2021 | 24 | 11 | 218.18% |
| Q4 2020 | 5 | 17 | 29.41% |
| Q3 2020 | 9 | 2 | 450.00% |
| Q2 2020 | 11 | 7 | 157.14% |
| Q1 2020 | 10 | 16 | 62.50% |
| Q4 2019 | 4 | 2 | 200.00% |
| Q3 2019 | 6 | 1 | 600.00% |
29 total buy trades, and 24 total sell trades (buy/sell ratio of 1.21%) were made by Kiniksa Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 11 | - |
| Q4 2023 | - | 5 | - |
| Q3 2023 | - | 4 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 2 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 7 | - |
| Q4 2020 | - | 4 | - |
| Q3 2020 | - | 2 | - |
| Q2 2020 | - | 5 | - |
| Q1 2020 | - | 7 | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Kiniksa Pharmaceuticals's stocks.
Kiniksa Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| NUVL | Nuvalent, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| GOSS | Gossamer Bio, Inc. |
| GPCR | Structure Therapeutics Inc. |
| CGEM | Cullinan Oncology, Inc. |
| COGT | Cogent Biosciences, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| ACLX | Arcellx, Inc. |
| NLTX | Neurogene Inc. |
| KURA | Kura Oncology, Inc. |
| PHAT | Phathom Pharmaceuticals, Inc. |
| CHRS | Coherus BioSciences, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| KRON | Kronos Bio, Inc. |
| REPL | Replimune Group, Inc. |
KNSA Ownership FAQ
Who Owns Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals is owned by institutional shareholders (55.34%), insiders (4.28%), and public (40.38%). The largest institutional shareholder of Kiniksa Pharmaceuticals is BLACKROCK INC. (5.96% of total shares) and the top mutual fund owner is WANGER ADVISORS TRUST (0.43% of total shares).
Who are the major institutional shareholders of Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals's major institutional shareholders are BLACKROCK INC., FAIRMOUNT FUNDS MANAGEMENT LLC, HHLR ADVISORS, LTD., VANGUARD GROUP INC, and BAKER BROS. ADVISORS LP. The top five shareholders own together 23.20% of the company's share outstanding.
How many Kiniksa Pharmaceuticals shareholders are there?
As of Mar 2024, there are 160 institutional shareholders of Kiniksa Pharmaceuticals.
What percentage of Kiniksa Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC owns 4.19M shares of Kiniksa Pharmaceuticals, representing 5.96% of the company's total shares outstanding, valued at $82.75M (as of Mar 2024).
What percentage of Kiniksa Pharmaceuticals is owned by FAIRMOUNT FUNDS MANAGEMENT LLC?
As of Mar 2024, FAIRMOUNT FUNDS MANAGEMENT LLC holds 3.2M shares of Kiniksa Pharmaceuticals (KNSA), compromising 4.55% of the company, valued at $63.23M.
What percentage of Kiniksa Pharmaceuticals is owned by HHLR ADVISORS, LTD?
HHLR ADVISORS, LTD is the third largest holder of Kiniksa Pharmaceuticals. The company owns 3.14M of the company's shares outstanding (worth $61.87M).